The procedure was performed by Raviender Bukkapatnam, MD, the medical director of Urology at Tampa General Hospital, which owns the ASC. The procedure, which takes 10-15 minutes to perform, involved injecting Bulkamid into the urethral wall to support the closing mechanism of the urethra. The FDA approved Bulkamid in 2020.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
